Solstice Advanced Materials, Inc (SOLS) Fair Value & Analysis
Basic Materials · US · Market cap $9.3B
Solstice Advanced Materials, Inc
SOLS · US
Fair value as of: Jul 17, 2026
From 24 valuation models · updated 21 days ago
Fair value updated Jul 17, 2026, revised from $20.15 to $29.89 (+48.3%) since Jun 24, 2026. Share price +0.1% over the past month.
Below-average quality, and screening another 52% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($38.85). The favourable scenario is already priced in.
- Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range ($20.92 to $38.85) leaves room in how you read the outcome.
Price vs Fair Value (19 months)
White line = price, green steps = our fair value per fiscal year. As of Jul 17, 2026.
How to read this chart
19‑month range $41.35 – $88.60 · fair‑value band $20.92 – $38.85 · the $62.18 price screens above the $29.89 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Jul 17, 2026.
Analysis
Solstice Advanced Materials, Inc (SOLS) currently trades at $62.18, while our model-based Fair Value estimate is $29.89, implying the stock looks roughly 51.9% overvalued today. We read business quality at 44/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Solstice Advanced Materials, Inc generated revenue of $4.0B at a net margin of 4.7%. Revenue grew 10.6% year over year. It earns a return on equity of 10.7%. Net debt stands at $1.9B. Fundamentals as of Jul 17, 2026
Our scenario range runs from $20.92 (bear case) to $38.85 (bull case); at $62.18, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 54% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -52%, SOLS screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Dividend Discount ($116.18) versus Asset-Based ($5.95). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 49 · Market factors (momentum, volatility) 28
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Solstice Advanced Materials, Inc. operates as a specialty chemicals and advanced materials company in the United States and internationally. It operates in two segments: Refrigerants & Applied Solutions (RAS), and Electronic & Specialty Materials (ESM).
Full company description
Solstice Advanced Materials, Inc. operates as a specialty chemicals and advanced materials company in the United States and internationally. It operates in two segments: Refrigerants & Applied Solutions (RAS), and Electronic & Specialty Materials (ESM). The RAS segment manufactures and sells low global warming potential (LGWP) refrigerants, blowing agents, solvents, and aerosol materials; and provides, aerosol propellants, cleaning solvents, pharmaceutical packaging materials, and alternative energy services under the Solstice, Genetron, and Aclar brands. The ESM segment offers electronic materials, fibers and laboratory life science chemicals for semiconductor, defense, pharmaceutical, and construction markets. This segment provides sputtering targets, lightweight high-strength fibers, and high-purity life science solutions under the Spectra, Fluka, and Hydranal brands. Solstice Advanced Materials, Inc. was incorporated in 2025 and is headquartered in Morris Plains, New Jersey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Solstice Advanced Materials, Inc reported revenue of $3.9B in FY2025 versus $3.6B in FY2022, a compound +2.7%/yr. Reported net income was $237M in FY2025, compounding −30.9%/yr from FY2022.
SOLS screens 52% overvalued. Compare with Linde plc →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Solstice Advanced Materials (SOLS) Stock Still Looks Pricey Despite Its 35% Slump
- Solstice Advanced Materials (SOLS) Q2 2026 Earnings Call Transcript
- Solstice Advanced Materials Inc. Q2 2026 Earnings Call Summary
- Is Solstice Advanced Materials (SOLS) Undervalued On Earnings, Guidance, And Acquisition Financing?
Peer Group
Specialty Chemicals · 680 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $520.74 | $226.27 | -57% |
| Nan Ya Plastics Corporation 1303 | 181.50 TWD | 255.83 TWD | +41% |
| Wanhua Chemical Group 600309 | ¥70.04 | ¥68.03 | -3% |
| Novozymes A/S NSISB | kr 428.20 | kr 179.66 | -58% |
| Asian Paints Limited ASIANPAINT | ₹2,689 | ₹668.81 | -75% |
| Solar Industries India Limited SOLARINDS | ₹18,236 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,560 | ₹351.84 | -77% |
| PT Chandra Asri Pacific Tbk TPIA | 1,805 IDR | 2,888 IDR | +60% |
| Linde India Limited LINDEINDIA | ₹7,115 | ₹757.93 | -89% |
| Berger Paints India Limited BERGEPAINT | ₹493.70 | ₹164.29 | -67% |
Compare Solstice Advanced Materials, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Solstice Advanced Materials, Inc (SOLS) overvalued or undervalued?
What is the fair value of SOLS?
What is the quality score of SOLS?
What is the revenue of Solstice Advanced Materials, Inc (SOLS)?
What is the net profit margin of SOLS?
Does Solstice Advanced Materials, Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Solstice Advanced Materials, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.